Sllk, control peptide for tsp1 inhibitor
CAS: 464924-27-4
Ref. 3D-PTA92427
| 25mg | To inquire | ||
| 50mg | To inquire |
Product Information
Sllk is a control peptide for TSP1 inhibitor that has been shown to induce apoptosis in cancer cells. This peptide is derived from the urine of Chinese patients and has been found to have elastase inhibitory activity. Sllk is an analog of the anticancer kinase inhibitor, which can be used as a tumor suppressor protein. It has been demonstrated that Sllk can inhibit the activity of various kinases involved in cancer progression, making it a promising candidate for future cancer therapies. The use of Sllk as a control peptide for TSP1 inhibitors can help researchers better understand the mechanisms underlying cancer cell growth and may lead to the development of novel anticancer treatments.
Chemical properties
Technical inquiry about: 3D-PTA92427 Sllk, control peptide for tsp1 inhibitor
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
